Aliases: Kir6.2, BIR.
KCNJ11 (potassium inwardly rectifying channel subfamily J member 11) is named by 5 disorder entries, including Congenital Isolated Hyperinsulinism; and Hyperinsulinemic Hypoglycemia.
The ingest layer carries no ai-gene-review core functions for KCNJ11 (0 terms): the review was created after the pinned ai-gene-review snapshot and will appear when the ingest is refreshed.
The two hyperinsulinism entries record the variant origin as germline and germline. In Congenital Isolated Hyperinsulinism the gene sits on KATP Channel Loss of Function, and in Hyperinsulinemic Hypoglycemia on K-ATP Channel Loss of Function. Diabetes mellitus records the gene as causative, and ClinGen rates it definitive for monogenic diabetes.
1 entry names KCNJ11 with no relationship type: Type 2 Diabetes Mellitus. ClinGen classifies KCNJ11 for 3 diseases; the one with no matching dismech entry is hyperinsulinemic hypoglycemia, familial, 2, which the hyperinsulinism entries cover only as a narrower MONDO mapping.
Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Congenital Isolated Hyperinsulinism | causative germline |
mechanism: KATP Channel Loss of Function
subtype: KATP-HI Diffuse; KATP-HI Focal
scoped to subtype: KATP-HI Diffuse
|
| Diabetes mellitus | causative |
mechanism: Monogenic Beta-Cell Dysfunction
subtype: PNDM2; TNDM3; maturity-onset diabetes of the young type 13
scoped to subtype: PNDM2, TNDM3, type 2 diabetes mellitus
|
| Hyperinsulinemic Hypoglycemia | causative germline |
mechanism: Focal Lesion Formation by Paternal K-ATP Variant and Somatic 11p15 Maternal Loss; K-ATP Channel Loss of Function
subtype: Diazoxide-Unresponsive HI; Diffuse HI; Focal HI
|
| Placental Abruption | susceptibility | |
| Type 2 Diabetes Mellitus |
untyped
Risk Factor
|
mechanism: Beta Cell Dysfunction
computational model: Topp Beta-Cell Mass / Insulin / Glucose Model
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| hyperinsulinemic hypoglycemia, familial, 2 MONDO:0011153 | AD | Limited 2026-06-02 |
no dismech entry |
| hyperinsulinemic hypoglycemia, familial, 2 MONDO:0011153 | AR | Definitive 2026-03-03 |
no dismech entry |
| monogenic diabetes MONDO:0015967 | AD | Definitive 2023-01-05 |
Diabetes mellitus
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.